BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perez-Castro L, Garcia R, Venkateswaran N, Barnes S, Conacci-Sorrell M. Tryptophan and its metabolites in normal physiology and cancer etiology. FEBS J 2023;290:7-27. [PMID: 34687129 DOI: 10.1111/febs.16245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Oldan JD, Giglio BC, Smith E, Zhao W, Bouchard DM, Ivanovic M, Lee YZ, Collichio FA, Meyers M, Wallack DE, Abernethy-leinwand A, Long PK, Trembath DG, Googe PB, Kowalski MH, Ivanova A, Ezzell J, Feinberg N, Thomas NE, Wong TZ, Ollila DW, Li Z, Moschos SJ. Increased Tryptophan, But Not Increased Glucose Metabolism, Predict Resistance of Pembrolizumab in Stage III/IV Melanoma.. [DOI: 10.1101/2022.12.06.22283165] [Reference Citation Analysis]
2 Liu Y, Xiang J, Liao Y, Peng G, Shen C. Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas. Front Mol Neurosci 2022;15. [DOI: 10.3389/fnmol.2022.1037835] [Reference Citation Analysis]
3 Xue C, Gu X, Zhao Y, Jia J, Zheng Q, Su Y, Bao Z, Lu J, Li L. Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes. Cancer Cell Int 2022;22:308. [PMID: 36217206 DOI: 10.1186/s12935-022-02730-8] [Reference Citation Analysis]
4 Hu Y, Liu Z, Tang H. Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis. Front Oncol 2022;12:977640. [DOI: 10.3389/fonc.2022.977640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Qian M, Xia Y, Zhang G, Yu H, Cui Y. Research progress on microRNA-1258 in the development of human cancer. Front Oncol 2022;12:1024234. [DOI: 10.3389/fonc.2022.1024234] [Reference Citation Analysis]
6 Li Z, Ding B, Ali MRK, Zhao L, Zang X, Lv Z. Dual Effect of Tryptamine on Prostate Cancer Cell Growth Regulation: A Pilot Study. IJMS 2022;23:11087. [DOI: 10.3390/ijms231911087] [Reference Citation Analysis]
7 Mammoli A, Bianconi E, Ruta L, Riccio A, Bigiotti C, Souma M, Carotti A, Rossini S, Suvieri C, Pallotta MT, Grohmann U, Camaioni E, Macchiarulo A. Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls. IJMS 2022;23:3981. [DOI: 10.3390/ijms23073981] [Reference Citation Analysis]